


Eurofins ADME BIOANALYSES
Pharmaceutical Manufacturing • 75 A, avenue de Pascalet, France • 51-100 Employees
Company overview
| Headquarters | 75 A, avenue de Pascalet, Vergèze, Occitanie 30310, FR |
| Website | |
| NAICS | 3254 |
| Keywords | Pharmacokinetics, Bioanalysis, Metabolism, Dermal Distribution And Absorption Studies |
| Founded | 1987 |
| Employees | 51-100 |
Key Contacts at Eurofins ADME BIOANALYSES
Mélissa Ollier
Study Director
Tiffany Margueron
Bioanalysis Study Director
Morgane Delobel
Study Director
Noémie Merle
Study Director
Eurofins ADME BIOANALYSES Email Formats
Eurofins ADME BIOANALYSES uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@eurofins.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@eurofins.com | 100% |
About Eurofins ADME BIOANALYSES
Eurofins is a Multinational providing contract research and services to the pharmaceutical, biotech, agrochemical industries. Our focus is on providing customers with services to optimize the discovery and safety of new medicines and compounds. We have over 8000 employees in 30 countries, but we act locally, understanding the value of close relationship and collaboration with our customers. Eurofins ADME BIOANALYSES is one of the 150 facilities of Eurofins. Through regular investment and continuous staff training, Eurofins ADME BIOANALYSES has long attracted and retained the best and brightest employees. Working for international pharmaceutical companies, we can provide with the following services: screening tests; to select the best leads: In-vivo pharmacokinetics: Cmax, Tmax, bioavailability ADME studies To evaluate absorption, distribution, metabolism and excretion of New Chemical Entities with either 14C or 3H molecules. Bioanalysis Development, transfer & validation of numerous analytical methods relating to animal, human biological fluids & tissues Toxicokinetics Human pharmacokinetic & Bioequivalence Phase I studies Phase II/III studies Metabolism Metabolism enzyme identification In-vivo & in-vitro metabolic profiles Dermal distribution and absorption studies In-vitro model such as Franz cells on animal & human skin to screen compounds, test new devices or new formulations or for regulatory purpose
Eurofins ADME BIOANALYSES revenue & valuation
| Annual revenue | $7,357,730 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $23,600,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Eurofins ADME BIOANALYSES has 30 employees across 8 departments.
Departments
Number of employees
Funding Data
Eurofins ADME BIOANALYSES has never raised funding before.
Frequently asked questions
4.8
40,000 users



